These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8864593)

  • 21. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of bisphosphonates in diseases of childhood.
    Srivastava T; Alon US
    Eur J Pediatr; 2003 Nov; 162(11):735-51. PubMed ID: 14523647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
    Li B; Ling Chau JF; Wang X; Leong WF
    J Cell Biochem; 2011 May; 112(5):1229-42. PubMed ID: 21465521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonates: from grandparents to grandchildren.
    Srivastava T; Alon US
    Clin Pediatr (Phila); 1999 Dec; 38(12):687-702. PubMed ID: 10618761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates and atherosclerosis.
    Ylitalo R
    Gen Pharmacol; 2000 Dec; 35(6):287-96. PubMed ID: 11922958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates use in children.
    Sebestyen JF; Srivastava T; Alon US
    Clin Pediatr (Phila); 2012 Nov; 51(11):1011-24. PubMed ID: 22935217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
    Gennari C; Nuti R; Agnusdei D; Camporeale A; Martini G
    Drug Saf; 1994 Sep; 11(3):179-95. PubMed ID: 7811400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonates' use in metastatic bone disease.
    Hubner RA; Houston SJ
    Hosp Med; 2005 Jul; 66(7):414-9. PubMed ID: 16025799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases.
    Francis MD; Valent DJ
    J Musculoskelet Neuronal Interact; 2007; 7(1):2-8. PubMed ID: 17396000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY; Lecart MP
    Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates and atherosclerosis: why?
    Bevilacqua M; Dominguez LJ; Rosini S; Barbagallo M
    Lupus; 2005; 14(9):773-9. PubMed ID: 16218486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of bisphosphonates in patients with metastatic bone disease.
    Berenson JR; Lipton A
    Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of action of bisphosphonates.
    Rodan GA
    Annu Rev Pharmacol Toxicol; 1998; 38():375-88. PubMed ID: 9597160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
    Kanis JA; Urwin GH; Gray RE; Beneton MN; McCloskey EV; Hamdy NA; Murray SA
    Am J Med; 1987 Feb; 82(2A):55-70. PubMed ID: 3103437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
    Fleisch H
    Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
    Kishimoto H
    Nihon Rinsho; 1998 Jun; 56(6):1531-6. PubMed ID: 9648477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacology and therapeutic utility of bisphosphonates.
    Lourwood DL
    Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.